1 nment, controlling for income per person and HIV seroprevalence.

2 IV transmission, even within an area of high HIV seroprevalence.

3 tion with high human immunodeficiency virus (HIV) seroprevalence (35%) to determine the prevalence of

4          The authors sought to determine the HIV seroprevalence among suicide victims in New York Cit

5 ethods may be useful in other areas in which HIV seroprevalence data among childbearing women and HIV

6                      Clinicians, using local HIV seroprevalence data and their knowledge of transmiss

7                                          The HIV seroprevalence declined from 15.2% in 1989 to 7.2% i

8 adjusted proportion was then contrasted with HIV seroprevalence estimates for the New York City gener

9 imately 0.038 to 0.059), contrasted with the HIV seroprevalence estimates for the New York City gener

10                                              HIV seroprevalence in ulcer patients was 6% (range by ci

11                                      Because HIV seroprevalence is at least 2 to 7% in "low-risk" gro

12          In a second patient cohort of mixed HIV seroprevalence, plasma PIIINP concentration was incr

13                         We conclude that the HIV seroprevalence rate among patients hospitalized for

14                We enrolled 436 patients; the HIV seroprevalence rate was 2%.

15 High antenatal human immunodeficiency virus (HIV) seroprevalence rates ( approximately 30%) with low

16                                              HIV seroprevalence was high in women at the remand centr

17                                              HIV seroprevalence was remarkably high, ranging from 11%

18              There was a trend of increasing HIV seroprevalence with increasing frequency of rectal b

19 l zidovudine program in a setting with 12.5% HIV seroprevalence would reduce perinatal HIV incidence